13F-HR filed by Frazier Life Sciences Management, L.P.
Frazier Life Sciences Management, L.P. filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 20:30:06 UTC, with 44 holding rows worth $4,030,605,205.
- Accession
- 0001892134-26-000007
- Filer
- CIK 1892134
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 44 entries on the cover page, a total value of $4,030,605,205 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,030,605,205 with VALUE read as dollars as filed, 13F file number 028-22504. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 7,679,684 | $656,459,388 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 18,988,902 | $461,810,097 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 29,475,188 | $432,106,256 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 6,652,013 | $389,941,002 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 9,874,511 | $260,983,326 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 5,282,915 | $143,589,630 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 9,539,147 | $136,600,585 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 391,319 | $130,137,047 | dollars as filed | |
| PALVELLA THERAPEUTICS INC | 697947109 | COMMON STOCK | 882,400 | $121,709,432 | dollars as filed | |
| ATTOVIA THERAPEUTICS INC | 04987L102 | COM | 7,046,271 | $120,773,085 | dollars as filed | |
| Braveheart Bio Inc | 10567X101 | COM | 5,267,321 | $106,399,884 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 12,466,489 | $91,005,370 | dollars as filed | |
| PARABILIS MEDICINES INC COM | 698955101 | Stock | 2,330,750 | $75,259,918 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 3,853,082 | $62,073,151 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 7,614,836 | $61,604,023 | dollars as filed | |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 15,755,491 | $61,446,415 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 934,852 | $61,195,412 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 720,338 | $56,625,770 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 2,743,939 | $52,354,356 | dollars as filed | |
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 225,155 | $51,297,064 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 1,902,320 | $50,107,109 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 8,729,516 | $45,917,254 | dollars as filed | |
| AURA BIOSCIENCES INC | 05153U107 | COMMON STOCK | 7,100,000 | $44,588,000 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 22,446,668 | $35,914,669 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 4,009,240 | $33,396,969 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 900,080 | $29,171,593 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 1,438,198 | $28,979,690 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 3,750,000 | $25,575,000 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 829,752 | $25,133,188 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 1,809,854 | $22,749,865 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 2,630,665 | $21,045,320 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 1,069,959 | $19,494,653 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 1,015,693 | $18,333,259 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 4,824,725 | $16,307,571 | dollars as filed | |
| Valneva SE ADR | 92025Y103 | COM | 2,291,666 | $14,173,954 | dollars as filed | |
| KAILERA THERAPEUTICS INC | 482931102 | COMMON STOCK | 1,200,000 | $13,704,000 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 1,000,000 | $11,930,000 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 751,672 | $10,125,022 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 4,447,910 | $8,628,945 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 500,333 | $6,329,212 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 1,113,752 | $5,746,960 | dollars as filed | |
| XILIO THERAPEUTICS INC | 98422T209 | COM | 422,505 | $3,823,670 | dollars as filed | |
| TCGX ACQUISITION CORP | G8708J109 | COM | 300,000 | $3,753,000 | dollars as filed | |
| IBIO INC | 451033708 | CMN | 1,953,467 | $2,305,091 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001892134-26-000007 | this filing | 2026-11-16 |